Business
ASX 200 investors underexposed to this potential ‘great news event’ – Motley Fool Australia
If an effective vaccine against the coronavirus were uncovered this week, many ASX 200 investors would be poorly positioned to benefit.
The silver bullet to slay the coronavirus and return life to normal remains elusive. But that doesn’t mean it might not be here sooner than most S&P/ASX 200 Index (ASX: XJO) investors are pricing in.
The world’s top institutions and brightest minds are working around the clock, after all, with record amounts of private and government funding pouring in.
However, recent setbacks with some leading vaccine trials, alongside announcements that any new vaccines may only prove 50–60% effective, …
-
General11 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
Noosa News17 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General14 hours agoTrump mulling whether to fire US Fed chair Powell
-
General13 hours agoChoosing an online exercise program can be confusing. Here’s what to look out for